Transport mechanism and pharmacology of the human GlyT1
Authors:
Top Cited Papers
- 20 March 2024
- Vol. 187 (7) , 1719-1732.e14
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (92157102)
- National Key Research and Development Program of China (2021YFA1301501)
- Chinese Academy of Sciences (XDB37030304)
This publication has 58 references indexed in Scilit:
- Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia SubjectsBiological Psychiatry, 2018
- UCSF ChimeraX: Meeting modern challenges in visualization and analysisProtein Science, 2017
- Glial glycine transporter 1 function is essential for early postnatal survival but dispensable in adult miceGlia, 2010
- Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the ratPsychopharmacology, 2008
- Glutamate and Schizophrenia: Beyond the Dopamine HypothesisCellular and Molecular Neurobiology, 2006
- The glycinergic control of spinal pain processingCellular and Molecular Life Sciences, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Cloning and expression of a glycine transporter from mouse brainFEBS Letters, 1992
- Cloning and expression of a glycine transporter reveal colocalization with NMDA receptorsNeuron, 1992
- The distribution of glycine in cat spinal cord and rootsLife Sciences, 1965